Significance of metallothioneins in aging brain

Neurochemistry International

Volumn 65, Issue 1, 2014, Pages 40-48

  Sharma, Sushil ^a   Ebadi, Manuchair ^b  

^a SAINT JAMES SCHOOL OF MEDICINE   (Anguilla)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Alzheimer's disease; Charnoly body; Growth inhibitory factor; Metallothioneins; Neuroprotection; Oxidative stress; Parkinson's disease; Reactive oxygen species

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 METHYLADENINE; 5 HYDROXYMETHYLCYTOSINE; 5 METHYLCYTOSINE; ALCOHOL; CADMIUM; COCAINE; COPPER; DNA; FERRITIN; METAL ION; METALLOPROTEIN; METALLOTHIONEIN; METALLOTHIONEIN II; METALLOTHIONEIN III; METALLOTHIONEIN IV; METHAMPHETAMINE; NEUROMELANIN; ROTENONE; SALSOLINOL; SELEGILINE; UBIDECARENONE; UNCLASSIFIED DRUG; ZINC; ZINC ION;

ACUPUNCTURE; AGING; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; AUTOPHAGY; BIOENERGY; BRAIN; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CELL CYCLE ARREST; COMPLEX FORMATION; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG BIOAVAILABILITY; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NEOPLASM; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SUBSTANTIA NIGRA;

ALZHEIMER'S DISEASE; CHARNOLY BODY; GROWTH INHIBITORY FACTOR; METALLOTHIONEINS; NEUROPROTECTION; OXIDATIVE STRESS; PARKINSON'S DISEASE; REACTIVE OXYGEN SPECIES;

AGING; ANIMALS; BRAIN; HUMANS; METALLOTHIONEIN; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS;

EID: 84893088967     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.12.009     Document Type: Review

References (122)

1. A. Ajjimaporn, J. Swinscoe, S. Shavali, P. Govitrapong, and M. Ebadi Metallothionein provides zinc-mediated protective efFe3+cts against methamphetamine toxicity in SK-N-SH cells Brain Res. Bull. 67 2005 466 475 (Pubitemid 41416741)
2. A. Ajjimaporn, P. Phansuwan-Pujito, M. Ebadi, and P. Govitrapong Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression Neurosci. Lett. 419 2007 59 63 (Pubitemid 46711138)
3. M. Aschner The functional significance of brain metallothionein FASEB J. 10 1996 1129 1136
4. M. Aschner, and A.K. West The role of MT in neurological disorders J. Alzheimers Dis. 8 2005 139 145 (Pubitemid 43227160)
5. M. Aschner, M.G. Cherian, C.D. Klaassen, R.D. Palmiter, J.C. Erickson, and A.I. Bush Metallothionein in brain-the role in physiology and pathology Toxicol. Appl. Pharmacol. 142 1997 229 242 (Pubitemid 28381012)
6. M. Aschner, T. Syverse, D.O. Souza, and J.B. Rocha Metallothioneins: mercury species-specific induction and their potential role in attenuating neurotoxicity Exp. Biol. Med. (Maywood) 231 2006 1468 1473 (Pubitemid 44547838)
7. S.G. Bell, and B.L. Vallee The MTs/thionein system: an oxidoreductive metabolic zinc link ChemBioChem 5 2009 55 62
8. C. Bertoni-Freddari, P. Fattoretti, T. Casoli, G. Di Stefano, B. Giorgetti, and M. Balietti Brain aging: the zinc connection Exp. Gerontol. 43 2008 389 393
9. + toxicity in human SH-S-Y5Y neuroblastoma cells J. Biol. Chem. 280 2005 2132 2140
10. S. Bolognin, F. Pasqualetto, C. Mucignat-Caretta, J. Scancar, R. Milacic, P. Zambenedetti, B. Cozzi, and P. Zatta Effects of a copper-deficient diet on the biochemistry, neural morphology and behavior of aged mice PLoS ONE 7 2012 e47063
11. D.J. Bonda, H.L. Lee, J.A. Blair, X. Zhu, G. Perry, and M.A. Smith Role of metal dyshomeostasis in Alzheimer disease Metallomics 3 2011 267 270
12. L. Cai, J.B. Klein, and Y.J. Kang MT inhibits peroxynitrite-induced DNA and lipoprotein damage J. Biol. Chem. 275 2001 38957 38960
13. M. Capasso, J.M. Jeng, M. Malavolta, E. Mocchegiani, and S.L. Sensi Zinc dyshomeostasis: a key modulator of neuronal injury J. Alzheimers Dis. 8 2005 93 108 (Pubitemid 43230132)
14. R.A. Cecília, C.R.A. Santos, A. Martinho, T. Quintela, and I. Gonçalves Neuroprotective and neuroregenerative properties of metallothioneins IUBMB LiFe 64 2012 126 135 (3+)
15. M.G. Cherian, and M.D. Apostolova Nuclear localization of MT during cell prolife3+ration and differentiation Cell. Mol. Biol. 46 2000 347 356
16. R.S. Chung, J. Hidalgo, and A.K. West New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration J. Neurochem. 104 2009 14 20 (Pubitemid 350265070)
17. C. Cipriano, M. Malavolt, L. Costarelli, R. Giacconi, E. Muti, N. Gasparini, M. Cardelli, D. Monti, E. Mariani, and E. Mocchegiani Polymorphisms in MT1a gene coding region are associated with longevity in Italian central female population Biogerontology 7 2006 357 365
18. V. Colangelo, J. Schurr, M.J. Ball, R.P. Pelaez, N.G. Bazan, and W.J. Lukiw Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor downregulation and up-regulation of apoptotic and pro-inflammatory signaling J. Neurosci. Res. 70 2002 462 473 (Pubitemid 35222383)
19. P. Coskun, J. Wyrembak, S. Schriner, H.W. Chen, C. Marciniack, F. Laferla, and D.C. Wallace A mitochondrial etiology of Alzheimer and Parkinson disease Biochim. Biophys. Acta 1820 2012 553 564
20. M.P. Cuajungco, and G.J. Lees Zinc metabolism in the brain: relevance to human neurodegenerative disorders Neurobiol. Dis. 4 1997 137 169 (Pubitemid 27465507)
21. S.R. Davis, and R.J. Cousins Metallothionein expression in animals: a physiological perspective on function J. Nutr. 130 2000 1085 1088 (Pubitemid 30233251)
22. K.E. Dineley, T.V. Votyakova, and I.J. Reynolds Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration J. Neurochem. 85 2003 563 570 (Pubitemid 36534479)
23. J. Dittmann, S.J. Fung, J.C. Vickers, M.I. Chuah, R.S. Chung, and A.K. West MTs biology in the ageing and neurodegenerative brain Neurotox. Res. 7 2005 87 93
24. S. Dzitoyeva, H. Chen, and H. Manev Effect of aging on 5-hydroxymethylcytosine in brain mitochondria Neurobiol. Aging 33 2012 2881 2891
25. M. Ebadi, and S. Sharma Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease Antioxid. Redox Signal. 5 2003 319 335 (Pubitemid 36793015)
26. M. Ebadi, and S. Sharma Vitamin E and ceonzyme Q10 in Parkinson's disease V.R. Preedy, R.R. Watson, The Encyclopedia of Vitamin E 2007 CAB International 439 449
27. 10 inhibits mitochondrial complex-1 downregulation and nuclear factor-kappa B activation J. Cell. Mol. Med. 8 2004 213 222 (Pubitemid 44145510)
28. M. Ebadi, S. Sharma, S. Wanpen, and S. Shavali Metallothionein isoforms attenuate peroxynityrite-induced oxidative stress in Parkinson's disease M. Ebadi, R.F. Pfeffier, Parkinson's Disease 2004 CRC Press
29. M. Ebadi, S.K. Sharma, A. Ajjimaporn, and S. Maanum Weaver mutant mouse in progression of neurodegeneration in Parkinson's disease M. Ebadi, R.F. Pfeffier, Parkinson's Disease 2004 CRC Press
30. M. Ebadi, S. Wanpen, S. Shavali, and S. Sharma Coenzyme Q10 stabilizes metallothionein in Parkinson's disease M. Hiramatsu, L. Packer, T. Yoshikava, MoleCu2+lar Interventions and Protection in Life Style-Related Diseases 2004 Markel Dekker, Inc. New York
31. M. Ebadi, S.K. Sharma, P. Ghafourifar, H. Brown-Borg, and H. El Refaey Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins Methods Enzymol. 396 2005 276 298 (Pubitemid 41603553)
32. M. Ebadi, H. Brown-Borg, S. Garrett, B. Singh, S. Shavali, and S. Sharma Metallothionein-mediated neuroprotection in genetically-engineered mice models of Parkinson's disease and aging Mol. Brain Res. 134 2005 67 75 (Pubitemid 40409496)
33. M. Ebadi, S. Wanpen, S. Shavali, and S. Sharma Coenzyme Q10 stabilizes mitochondria in Parkinson's disease M. Hiramtsu, T. Yoshikawa, L. Packer, Molecular Interventions in Life-Style-Related Diseases 2005 CRC Taylor & Francis Group 127 153
34. J.K. Eibl, Z. Abdallah, and G.M. Ross Zinc-MTs: a potential mediator of antioxidant defence mechanisms in response to dopamine-induced stress Can. J. Physiol. Pharmacol. 88 2010 305 312
35. J.C. Erickson, G. Hollopeter, S.A. Thomas, G.J. Froelick, and R.D. Palmiter Disruption of the metallothionein-III gene in mice: analysis of brain zinc, behavior, and neuron vulnerability to metals, aging, and seizures J. Neurosci. 17 1997 1271 1281 (Pubitemid 27073729)
36. B.A. Fowler et al. Nomenclature of metallothionein, Metallothionein II Experimentia Suppl. 52 1987 19
37. V. Frazzini, E. Rockabrand, E. Mocchegiani, and S.L. Sensi Oxidative stress and brain aging: is zinc the link? Biogerontology 7 2006 307 314 (Pubitemid 44515717)
38. R. Giacconi, S. Kanoni, P. Mecocci, M. Malavolta, D. Richter, S. Pierpaoli, L. Costarelli, C. Cipriano, E. Muti, F. Mangialasche, F. Piacenza, S. Tesei, R. Galeazzi, E.V. Theodoraki, F. Lattanzio, G. Dedoussis, and E. Mocchegiani Association of MT1A haplotype with cardiovascular disease J. Nutr. Biochem. 21 2010 1008 1014
39. R. Giacconi, M. Malavolta, L. Costarelli, F. Busco, R. Galeazzi, G. Bernardini, N. Gasparini, and E. Mocchegiani Comparison of intracellular zinc signals in nonadherent lymphocytes from young-adult and elderly donors: role of zinc transporters (Zip family) and proinflammatory cytokines J. Nutr. Biochem. 23 2012 1256 1263
40. M. Giralt, M. Penkova, J. Hernandez, A. Molinero, J. Carrasco, N. Lago, J. Camats, I.L. Campbell, and J. Hidalgo MT-1+2 deficiency increases brain pathology in transgenic Mice with astrocyte-targeted expression of interleukin 6 Neurobiol. Dis. 9 2002 319 338 (Pubitemid 34442080)
41. Q. Hao, and W. Maret Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease J. Alzheimers Dis. 8 2010 161 170 (Pubitemid 43230133)
42. J. Hidalgo, B. Castellano, and I.L. Campbell Regulation of Brain Metallothionein Curr. Top. Neurochem. 1 1997 1 26
43. J. Hidalgo, M. Aschner, P. Zatta, and M. Vasák Roles of the MTs family of proteins in the central nervous system Brain Res. Bull. 55 2001 133 145 (Pubitemid 32722153)
44. E. Hijova MTss and zinc: their functions and interactions Bratisl. Lek. Listy 105 2004 230 234
45. I. Hozumi Roles and therapeutic potential of MTs in neurodegenerative diseases Curr. Pharm. Biotechnol. 14 2013 408 413
46. I. Hozumi, T. Inuzuka, and S. Tsuji Brain injury and growth inhibitory factor (GIF) - a minireview Neurochem. Res. 23 1988 319 328
47. I. Hozumi, T. Inuzuka, H. Ishiguro, M. Hiraiwa, Y. Uchida, and S. Tsuji Immunoreactivity of growth inhibitory factor in normal rat brain and after stab wounds - an immunocytochemical study using confocal laser scan microscope Brain Res. 741 1996 197 204 (Pubitemid 26426316)
48. I. Hozumi, T. Inuzuka, M. Hiraiwa, Y. Uchida, T. Anezaki, H. Ishiguro, H. Kobayashi, Y. Uda, T. Miyatake, and S. Tsuji Changes of growth-inhibitory factor after stab wounds in rat brain Brain Res. 688 1999 143 148
49. I. Hozumi, T. Hasegawa, A. Honda, K. Ozawa, Y. Hayashi, K. Hashimoto, M. Yamada, A. Koumura, T. Sakurai, A. Kimura, Y. Tanaka, M. Satoh, and T. Inuzuka Patterns of levels of biological metals in CSF differ among neurodegenerative diseases J. Neurol. Sci. 303 2011 95 99
50. H. Hua, L. Münter, A. Harmeier, O. Georgiev, G. Multhaup, and W. Schaffner Toxicity of AD-associated Aβ peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability Biol. Chem. 392 2011 919 926
51. M. Itoh, M. Ebadi, and S. Swanson The presence of zinc-binding proteins in brain J. Neurochem. 41 1983 823 829 (Pubitemid 13050083)
52. J.R.H. Kägi, K.T. Suzuki, N. Imura, and Kimura Metallothionein vol. III 1993 Birkhäuser Verlag Basel 29 56
53. K.M. Kanninen, A. Grubman, J. Meyerowitz, C. Duncan, J.L. Tan, S.J. Parker, P.J. Crouch, B.M. Paterson, J.L. Hickey, P.S. Donnelly, I. Volitakis, I. Tammen, D.N. Palmer, and A.R. White Increased zinc and manganese in parallel with neurodegeneration, synaptic protein changes and activation of Akt/GSK3 signaling in ovine CLN6 neuronal ceroid lipofuscinosis PLoS ONE 8 2013 e58644
54. 10 Neurochem. Res. 31 2006 303 311 (Pubitemid 43829320)
55. M.E. Knoch, K.A. Hartnett, H. Hara, K. Kandler, and E. Aizenman Microglia induce neurotoxicity via intraneuronal Zn(2+) release and a K(+) current surge Glia 56 1 2008 89 96 (Pubitemid 350172734)
56. A.H. Koeppen, R.L. Ramirez, D. Yu, S.E. Collins, J. Qian, P.J. Parsons, K.X. Yang, Z. Chen, J.E. Mazurkiewicz, and P.J. Feustel Friedreich's ataxia causes redistribution of iron, copper, and zinc in the dentate nucleus Cerebellum 11 2012 845 860
57. S. Kojima, A. Shimada, T. Morita, Y. Yamano, and T. Umemura Localization of metallothioneins-I & -II and -III in the brain of aged dog J. Vet. Med. Sci. 61 1999 343 349 (Pubitemid 129620051)
58. P. Kooncumchoo, S. Sharma, J. Porter, P. Govitrapong, and M. Ebadi Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons J. Mol. Neurosci. 28 2006 125 141
59. A.E. Lang, and A.M. Lozano Medical progress: Parkinson disease. Part 1 and 2 N. Engl. J. Med. 339 1998 1130 1143
60. Y.K.J. Leung, M. Pankhurst, S.A. Dunlop, S. Ray, J. Dittmann, E.D. Eaton, P. Paluma, R. Sillard, M.I. Chuah, A.K. West, and R.S. Chung Metallothionein induces a regenerative reactive astrocyte phenotype via JAK/STAT and RhoA signalling pathways Exp. Neurol. 221 2010 98 106
61. M.T. Lin, and M.F. Beal Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases Nature 443 2006 787 795 (Pubitemid 44622683)
62. Liuzzi, J.P., Yoo, C., 2013. Role of zinc in the regulation of autophagy during ethanol exposure in human hepatoma cells. Biol. Trace Elem. Res. (in press).
63. M. Malavolta, A. Basso, F. Piacenza, R. Giacconi, L. Costarelli, S. Pierpaoli, and E. Mocchegiani Survival study of metallothionein-1 transgenic mice and respective controls (C57BL/6J): influence of a zinc-enriched environment Rejuvenation Res. 15 2012 140 143
64. B.A. Masters, C.J. Quaife, J.C. Erickson, E.J. Kelly, G.J. Froelick, B.P. Zambrowicz, R.L. Brinster, and R.D. Palmiter Metallothionein-III is expressed in neurons that sequester zinc in synaptic vesicles J. Neurosci. 14 1994 5844 5857 (Pubitemid 24307781)
65. M.P. Mattson Cellular and neurochemical aspects of the aging human brain J.B. Halter, J.G. Ouslander, M.E. Tinetti, S. Studenski, K.P. High, S. Asthana, Hazzard's Geriatric Medicine and Gerontology 2009 McGraw-Hill New York (chapter 61)
66. M.P. Mattson, and T. Magnus Aging and neuronal vulnerability Nat. Rev. Neurosci. 7 2006 278 294
67. 7-MTs-3 Free Radical Biol. Med. 50 2011 1471 1479
68. G. Meloni, P. Faller, and M. Vasák Redox silencing of copper in metal-linked neurodegenerative disorders: reaction of Zn7MTs-3 with Cu2+ ions J. Biol. Chem. 282 2007 16068 16078 (Pubitemid 47100352)
69. E. Mocchegiani, and M. Malavolta Zinc dyshomeostasis, ageing and neurodegeneration: implications of A2M and inflammatory gene polymorphisms J. Alzheimers Dis. 12 2007 101 109 (Pubitemid 47396309)
70. E. Mocchegiani, M. Muzzioli, and R. Giacconi Zinc, metallothioneins, immune responses, survival and ageing Biogerontology 1 2000 133 143
71. E. Mocchegiani, R. Giacconi, C. Cipriano, M. Muzzioli, P. Fattoretti, C. Bertoni-Freddari, G. Isani, P. Zambenedetti, and P. Zatta Zinc-bound metallothioneins as potential biological markers of ageing Brain Res. Bull. 55 2001 147 153 (Pubitemid 32722154)
72. E. Mocchegiani, C. Bertoni-Freddari, F. Marcellini, and M. Malavolta Brain, aging and neurodegeneration: role of zinc ion availability Prog. Neurobiol. 75 2005 367 390 (Pubitemid 40827125)
73. E. Mocchegiani, M. Malavolta, L. Costarelli, R. Giacconi, C. Cipriano, F. Piacenza, S. Tesei, A. Basso, S. Pierpaoli, and F. Lattanzio Zinc, metallothioneins and immunosenescence Proc. Nutr. Soc. 693 2010 290 299
74. E. Mocchegiani, L. Costarelli, R. Giacconi, F. Piacenza, A. Basso, and M. Malavolta Zinc, metallothioneins and immunosenescence: effect of zinc supply as nutrigenomic approach Biogerontology 12 2011 455 465
75. 3+)-gene interactions in ageing and inflammatory age-related diseases: implications for treatments Ageing Res. Rev. 11 2012 297 319
76. E. Mocchegiani, J. Romeo, M. Malavolta, L. Costarelli, R. Giacconi, L.E. Diaz, and A. Marcos Zinc: dietary intake and impact of supplementation on immune function in elderly Age (Dordr) 53 2012 839 860
77. E. Mocchegiani, L. Costarelli, A. Basso, R. Giacconi, F. Piacenza, and M. Malavolta Metallothioneins, ageing and cellular senescence: a future therapeutic target Curr. Pharm. Des. 19 2013 1753 1764
78. 2+ ratio, physical function, disability, and mortality risk in older elderly (ilSIRENTE study) Age (Dordr) 34 2012 539 552
79. E. Mocchegiani, J. Romeo, M. Malavolta, L. Costarelli, R. Giacconi, L.E. Diaz, and A. Marcos Zinc: dietary intake and impact of supplementation on immune function in elderly Age (Dordr) 35 2013 839 860
80. T. Niccoli, and L. Partridge Ageing as a risk factor for disease Curr. Biol. 22 2012 R741 R752
81. M. Nordberg Metallothioneins: historical review and state of knowledge Talanta 46 1998 243 254 (Pubitemid 28205502)
82. R.D. Palmiter, S.D. Findley, T.E. Whitmore, and D.M. Durnam MT-III, a brain-specific member of the metallothionein gene family Proc. Natl. Acad. Sci. USA 89 1992 6333 6337
83. P. Palumaa, I. Tammiste, K. Kruusel, L. Kangur, H. Jörnvall, and R. Sillard Metal binding of MT-3 versus MT-2: lower affinity and higher plasticity Biochim. Biophys. Acta 1747 2005 205 211 (Pubitemid 40215161)
84. M.Ø. Pedersen, R. Jensen, D.S. Pedersen, A.D. Skjolding, C. Hempel, L. Maretty, and M. Penkowa MTs-I+II in neuroprotection Biofactors 35 4 2009 315 325
85. L.M. Plum, L. Rink, and H. Haase The essential toxin: impact of zinc on human HEALTH Int. J. Environ. Res. Public Health 7 2010 1342 1365
86. W. Rachidi, F. Chimienti, M. Aouffen, A. Senator, P. Guiraud, M. Seve, and A. Favier Prion protein protects against zinc-mediated cytotoxicity by modifying intracellular exchangeable zinc and inducing metallothionein expression J. Trace. Elem. Med. Biol. 23 2009 214 223
87. P. Sangchot, S.K. Sharma, B. Chatsawang, P. Govitropong, and M. Ebadi Deferoxamine attenuates iron induced oxidative Stress and prevents mitochondrial aggregation and α-synuclein translocation in SK-N-SH cells in culture Dev. Neurosci. 24 2002 143 153 (Pubitemid 36151444)
88. A. Santon, V. Albergoni, G. Santovito, G.C. Sturniolo, and P. Irato Relationship between metallothionein and zinc in the protection against DNA damage in zinc-treated Long-Evans Cinnamon rat liver Eur. J. Histochem. 48 2004 317 320
89. S.K. Sharma, and M. Ebadi Metallothionein attenuates 3- morpoholinosydnonimone (SIN-1)-induced oxidative and nitrative stress in dopaminergic neurons Antioxid. Redox Signal. 5 2003 251 264 (Pubitemid 36793009)
90. S.K. Sharma, and M. Ebadi An improved method for analyzing coenzyme Q homologues and multiple detection of rare biological samples J. Neurosci. Method 137 2004 1 8 (Pubitemid 38766152)
91. 18F-DOPA in weaver mutant mice Mol. Brain Res. 139 2005 23 30 (Pubitemid 41583586)
92. S. Sharma, and M. Ebadi SPECT neuroimaging in translational research of CNS disorders Neurochem. Int. 52 2008 352 362
93. S. Sharma, and M. Ebadi Therapeutic potential of metallothioneins in Parkinson's disease Timothy F. Hahn, Julian Werner, New Research on Parkinson's Disease 2008 Nova Science Publishers New York 1 28
94. S. Sharma, and M. Ebadi Metallothioneins as early & sensitive biomarkers of redox signaling in neurodegenerative disorders J. Inst. Integr. Omics Appl. Biotech. (IIOAB J.) 2 2011 98 106
95. S. Sharma, and M. Ebadi Therapeutic potential of metallothioneins as anti-inflammatory agents in polysubstance abuse J. Inst. Integr. Omics Appl. Biotech. (IIOAB J.) 2 2011 50 61
96. S. Sharma, and M. Ebadi In-vivo molecular imaging in Parkinson's disease M. Ebadi, R. Pfieffer, Parkinson's Disease 2012 CRC Press (chapter 57)
97. Sharma, S., Ebadi, M., 2014. Antioxidant targeting in neurodegenerative disorders. In: Laher I. (Ed.), System Biology of Oxidative Stress, Springer Verlag, Germany, pp. 1-30. (chapter 85).
98. S.K. Sharma, U. Nayar, M.C. Maheshwari, and G. Gopinath Ultrastructural studies of P-cell morphology in developing normal and undernourished rat cerebellar cortex. Morphological correlates Neurol. India 34 1986 323 327
99. S.K. Sharma, U. Nayar, M.C. Maheshwari, and B. Singh Effect of undernutrition on developing rat cerebellum: some electrophysiological and neuromorphological correlates J. Neurol. Sci. 78 1987 261 272 (Pubitemid 17062037)
100. S.K. Sharma, W. Selvamurthy, and K. Dakshinamurti Effect of environmental neurotoxins in the developing brain Biometeorology 2 1993 447 455
101. +)-induced apoptosis in dopaminergic neurons J. Neurocytol. 32 2003 329 343 (Pubitemid 38197813)
102. 10 in Parkinson's disease Methods Enzymol. 382 2004 488 509 (Pubitemid 38240807)
103. 10 Brain Res. Bull. 70 2006 22 32 (Pubitemid 43783378)
104. S. Sharma, A. Rais, R. Sandhu, W. Nel, and M. Ebadi Clinical significance of MTs in cell therapy and nanomedicine Int. J. Nanomed. 8 2013 1477 1488
105. S. Sharma, C.S. Moon, A. Khogali, A. Haidous, A. Chabenne, C. Ojo, M. Jelebinkov, Y. Kurdi, and M. Ebadi Biomarkers of Parkinson's disease (recent update) Neurochem. Int. 63 2013 201 229
106. R.K. Stankovic, R.S. Chung, and M. Penkowa Metallothioneins I and II: neuroprotective significance during CNS pathology Int. J. Biochem. Cell Biol. 39 2007 484 489 (Pubitemid 46096789)
107. K. Stepien, A. Wilczok, A. Zaidel, A. Dzierzega-Lecznar, and T. Wilczok Peroxynitrite mediated linoleic acid oxidation and tyrosine nitration in the presence of Synthetic neuromelanin Acta Biochim. Pol. 47 2000 931 940
108. B. Szewczyk Zinc homeostasis and neurodegenerative disorders Front. Aging Neurosci. 5 2013 33
109. C. Treiber Metals on the brain Sci. Aging Knowledge Environ. 36 2005 pe27
110. G. Trendelenburg, K. Prass, J. Priller, K. Kapinya, A. Polley, C. Muselmann, K. Ruscher, U. Kannbley, A.O. Schmitt, S. Castell, F. Wiegand, A. Meisel, A. Rosenthal, and U. Dirnag Serial analysis of gene expression identifies MT-II as major neuroprotective gene in mouse focal cerebral ischemia J. Neurosci. 22 2002 5879 5888 (Pubitemid 35387632)
111. Y. Uchida, K. Takio, K. Titani, Y. Ihara, and M. Tomonaga The growth inhibitory factor that is deficient in the Alzheimer's-disease brain is a 68-amino acid metallothionein-like protein Neuron 7 1991 337 347
112. Y. Uchida, F. Gomi, T. Masumizu, and Y. Miura Growth inhibitory factor prevents neurite extension and the death of cortical neurons caused by high oxygen exposure through hydroxyl radical scavenging J. Biol. Chem. 277 2002 32353 32359 (Pubitemid 34969053)
113. M. Vasak, and J.R.H. Kägi R.B. King, Encyclopedia of Inorganic Chemistry 1994 J Wiley and Sons Ltd. New York 2229 2241
114. M. Vašák, and G. Meloni Chemistry and biology of mammalian metallothioneins J. Biol. Inorg. Chem. 16 2011 1067 1078
115. T. Wen, X. Fan, M. Li, J. Han, X. Shi, and L. Xing Changes of MTs 1 and 3 mRNA levels with age in brain of senescence-accelerated mice and the effects of acupuncture Am. J. Chin. Med. 34 2006 435 447 (Pubitemid 43740980)
116. B.L. Williams, K. Yaddanapudi, C.M. Kirk, A. Soman, M. Hornig, and W.I. Lipkin Metallothionein and zinc dysregulation contribute to neurodevelopmental damage in a model of perinatal viral infection Brain Pathol. 16 2006 1 14
117. T. Wyman, D. Rohrer, P. Kirigiti, H. Nichols, K. Pilcher, G. Nilaver, and C. Machida Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases Gene Ther. 6 1999 1648 1660 (Pubitemid 29485939)
118. J.Y. You, D. Oh, C.Y. Choi, D.G. Lee, K.S. Hahm, A.R. Moon, and H.G. Jeong Protective efFe3+ct of metallothionein-II on DNA damage in response to reactive oxygen species Biochim. Biophys. Acta 1573 2002 33 38 (Pubitemid 35279786)
119. W.H. Yu, W.J. Lukiw, C. Bergeron, H.B. Niznik, and P.E. Fraser Metallothionein III is reduced in Alzheimer's disease Brain Res. 894 2001 37 45 (Pubitemid 32197596)
120. P. Zatta, D. Drago, P. Zambenedetti, S. Bolognin, E. Nogara, A. Peruffo, and B. Cozzi Accumulation of copper and other metal ions, and MTs I/II expression in the bovine brain as a function of aging J. Chem. Neuroanat. 36 2008 1 5
121. L. Zecca, R. Fariello, P. Riederer, D. Sulzer, A. Gatti, and D. Tampellini The absolute concentrations of nigral neuromelanin, assayed by a new sensitive method, increases throughout life and it dramatically decreased in PD FEBS Lett. 510 2002 216 220 (Pubitemid 34093828)
122. J. Zheng Research progress in brain-specific MTs-III Sheng Li Ke Xue Jin Zhan 29 1998 325 330